Why is Valiant Laborato falling/rising?

As of 20-Aug, Valiant Laboratories Ltd is experiencing a decline in its stock price, currently at 88.00, which reflects a decrease of 0.5 or 0.56%. The stock has been losing value for the last two days, with a total drop of 1.95% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite reporting very positive results in June, including a 160% growth in net profit and significant increases in profit before tax and net sales, the company faces challenges such as weak long-term fundamental strength, with an average return on equity of 0% and negative operating profits. Furthermore, the stock has underperformed against the benchmark, with a year-to-date decline of 20.54% compared to a 4.76% increase in the Sensex.
In the broader market context, Valiant Laboratories Ltd's short-term performance has been unfavorable compared to the benchmark, as it has generated a return of -0.28% over the past week while the Sensex has risen by 1.64%. The stock's liquidity is adequate for trading, but there has been a significant drop in investor participation, with delivery volume falling by 71.13% against the 5-day average. This combination of declining stock performance, weak investor interest, and consistent underperformance against the benchmark suggests a challenging environment for Valiant Laboratories Ltd, contributing to its current price decline.